🇺🇸 FDA
Pipeline program

Tecentriq 1 200 mg concentrate for solution for infusion

Phase 2 small_molecule active

Quick answer

Tecentriq 1 200 mg concentrate for solution for infusion for (Diffuse) Large B-cell Lymphoma is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
(Diffuse) Large B-cell Lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials